Lumosa Therapeutics Co., Ltd. announced a private placement to issue 5,000,000 common shares at an issue price of TWD 10 per share for the gross proceeds of TWD 50,000,000 on May 14, 2024. The transaction has been approved by shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
180 TWD | -4.00% | -2.44% | +163.54% |
05-14 | Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.54% | 955M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- 6535 Stock
- News Lumosa Therapeutics Co., Ltd.
- Lumosa Therapeutics Co., Ltd. announced that it expects to receive TWD 50 million in funding